Association of Frailty and Delirium in Elderly Hip Fracture Patients
NCT ID: NCT05246254
Last Updated: 2023-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2022-02-01
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Anesthesia on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery
NCT02213380
Prevention of Delirium Among Elderly Patients With Hip Fractures
NCT03470662
Associations of Postoperative Delirium With Perioperative Frailty Worsening and Their Combined Effect on 1-Year Mortality in Older Surgical Patients
NCT07259850
Risk Early Warning Management for Postoperative Hip Fracture Rehabilitation and Delirium Prevention in Elderly Patients
NCT06966947
Biomarkers and Postoperative Delirium in Elderly Patients
NCT05454228
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, this project intends to conduct a prospective cohort study. Patients will be divided into three groups according to frailty index (FI) before surgery, and delirium status will be evaluated by using scales after surgery, so as to explore the diagnostic and predictive value of frailty on POD. Once confirmed, the results of this study will be helpful for the early identification, screening, diagnosis and evaluation of treatment effect of POD. It is of great scientific significance and social benefit to reduce the incidence of POD, improve the prognosis of vulnerable patients and reduce the burden of disease.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prefrailty group
According to the frailty index(FI) and FI =0.12\~0.25
Frailty index scale
There are clinically common scales for assessing weakness and delirium.
Frailty group
According to the frailty index(FI) and FI≥ 0.25
Frailty index scale
There are clinically common scales for assessing weakness and delirium.
Nonfrailty group
According to the frailty index(FI) and FI\<0.12
Frailty index scale
There are clinically common scales for assessing weakness and delirium.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Frailty index scale
There are clinically common scales for assessing weakness and delirium.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Older than 65 years;
* Patients signed informed consent;
* American Society of Anesthesiologist (ASA) Rated I- III;
* The surgery was performed by the same anesthesia and surgical team.
Exclusion Criteria
* A history of cognitive impairment;
* Unable to complete the cognitive function test;
* Mental disorder during initial assessment;
* Patients suffering from mental illness or substance use disorder;
* Incomplete or lost data during follow-up.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Municipal Administration of Hospitals
OTHER_GOV
Beijing Tsinghua Chang Gung Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Huan Zhang, PhD
Role: PRINCIPAL_INVESTIGATOR
Beijing Tsinghua Changgeng Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BTCH-MZ-007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.